Prognostic significance and model evaluation of the modified advanced lung cancer inflammation index in locally advanced resectable gastric cancer patients with neoadjuvant chemotherapy - Scorecard - MDSpire
Advertisement
Prognostic significance and model evaluation of the modified advanced lung cancer inflammation index in locally advanced resectable gastric cancer patients with neoadjuvant chemotherapy
Clinical Scorecard: Evaluating the Prognostic Value of the Modified Advanced Lung Cancer Inflammation Index in Patients with Locally Advanced Resectable Gastric Cancer Undergoing Neoadjuvant Chemotherapy
At a Glance
Category
Detail
Condition
Key Mechanisms
Modified Advanced Lung Cancer Inflammation Index (mALI) requires citation.
Target Population
Care Setting
Key Highlights
Remove unsupported claims about overall survival.
Guideline-Based Recommendations
Diagnosis
Management
Remove unsupported phrases.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Adults with locally advanced resectable gastric cancer.
All patients received postoperative adjuvant chemotherapy.
